Dr Francesco Giganti presenting results of the PAIR-1 study at #ECR2025, that demonstrates that Pi™ (Prostate Intelligence™) matches MDT-supported radiologists in accurately detecting prostate cancer on MRI.
We asked @ProfPadhani to choose the most important practice breakthroughs in prostate cancer diagnosis in 2024. The below @TheLancet Commission lists interventions to tackle the surge in cases and shift the case mix from advanced to earlier-stage disease: https://t.co/QD8fMRJ5wc
Excellent overview of prostate MRI reporting best practice by Benjamin Spilseth, Francesco Giganti @giga_fra & @SilviaChangMD, covering diagnosis, quality, recurrence, monitoring and treatment and new technologies like AI.
https://t.co/d6Td0b3tuj
Call for abstracts for #RSNA24!
Submission deadline: 7 August.
More details here: https://t.co/udVL6zZRG2
We'll be exhibiting! Visit the Lucida Medical stand to see a demo of our software Pi™ (Prostate Intelligence™).
#RSNA2024#radtwitter
Earlier this year @macmillancancer invested in our pioneering new AI platform, Pi™, that aims to improve the speed & accuracy of prostate cancer tests.
This great talk covers the role that charities can play in supporting start-ups via impact investment.
https://t.co/J5hZIEGaW0
ICIS 2023 - Cancer Imaging: Current guidelines for best practice ‘On Demand’
Did you miss our 22nd meeting at the British Museum?
Don't worry – we've got you covered!
Packed with insights, innovations & the latest updates in cancer imaging:
1️⃣Day:£99
2️⃣Days:£160
3️⃣Days:£230
Here's a not-so-fun fact: while #MRI is the gold standard for #ProstateCancer diagnosis, there's still a 12% miss rate. We can do better!
Come see how we are harnessing the power of MRI + AI to improve outcomes at #RSNA23. Find us at booth 4862 by the #AI Showcase.
See you there!
As we step into the heart of November, we're happy to support a cause close to our💙
We proudly stand with the global movement dedicated to raising awareness about prostate health.
In our commitment to advancing patient care, we're excited to bring you Prostate Intelligence™ 🧵
Prostate cancer diagnosis just got easier with CE Mark
Certification of Lucida Medical's New Al groundbreaking software.
We are proud to announce that we have received Class Ilb CE certification for our Al-based prostate cancer detection software, Prostate Intelligence™ (Pi)™🧵
Excellent! There is a slightly more detailed but similar version online on @ProstateMatters
https://t.co/Nb8mClNICi
All men should be able to make an informed choice.
Our team is recruiting survey-participants ages 40-75 to help us develop a sexual quality-of-life questionnaire that will improve future prostate cancer patient care. Your contribution makes a difference.💙
Survey: https://t.co/JO2erip4lu
Questions? Send to [email protected]
Exclusive new content on our Youtube channel!
Enjoy this 'LI-RADS' webinar from Dr Heiken & Prof Lucidarme.
See them both speak at #ICIS2022 "Cancer Imaging: An All-Inclusive Specialty'
12-14 September in #Boston, USA
#radtwitter#LIRADS#cancerimaging
https://t.co/YKLV1v1gwa
Due to technical issues on our website we have extended the #ICIS2022 abstract deadline by one week. Please submit your #cancerimaging abstracts by Wednesday 8 June.
Join us in Boston from 12-14 September:
https://t.co/bOdNx7ygnu
Signposting #HCPs & #CancerPatients to real-time info & contacts – across multiple languages, inside #Ukraine & throughout much of #Europe
https://t.co/a5FPcn9bgJ in English
https://t.co/yWgTpJ5MYF in Ukranian
We're looking for interns!
We’re recruiting up to four interns in machine learning and/or clinical research to help us develop the next generation of AI-powered software to find cancer early.
https://t.co/H5F7akyoBR